RecruitingNCT06306443
Extended-release or under-the-tongue buprenorphine for people leaving jail
About this title
Read the official source — NCT06306443Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Baltimore and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 20, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 240
- Sponsor
- Friends Research Institute, Inc.
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06306443
- Official title
Show the full official title
A Comparative Effectiveness Trial of Sublingual Versus Extended-release Buprenorphine With Individuals Leaving a Carceral Setting
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Baltimore
Questions about this study
Who is behind this study?
The study sponsor is Friends Research Institute, Inc., a research institute.
Does this study involve medication?
Yes. The study involves medication, including extended-release buprenorphine (XR-B).
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
